Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors

• Nora V. Lieske,

  Affiliation Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway

  ⨯
• Kristian Tonby,

  Affiliations Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway

  ⨯
• Dag Kvale,

  Affiliations Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Kristian Gerhard Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway

  ⨯
• Anne M. Dyrhol-Riise,

  Affiliations Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Kristian Gerhard Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway

  ⨯
• Kjetil Tasken

  * E-mail: kjetil.tasken@ncmm.uio.no

  Affiliations Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway, Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, Kristian Gerhard Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway, Biotechnology Centre, University of Oslo, Oslo, Norway

  ⨯